Cargando…

Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands

BACKGROUND: Use of the direct oral anticoagulant rivaroxaban has strongly increased in Europe since its market approval for non-valvular atrial fibrillation in 2011. Patients characteristics of rivaroxaban initiators may have changed over time but this has not been investigated so far. OBJECTIVE: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Voss, Annemarie, Smits, Elisabeth, Swart, Karin M. A., Balabanova, Yanina, Brobert, Gunnar, Suzart-Woischnik, Kiliana, Herings, Ron M. C., Schink, Tania, Haug, Ulrike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232386/ https://www.ncbi.nlm.nih.gov/pubmed/36725812 http://dx.doi.org/10.1007/s40801-022-00350-2

Ejemplares similares

Use of rivaroxaban in Germany: a database drug utilization study of a drug started in hospital
por: Jobski, Kathrin, et al.
Publicado: (2014)

Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2019)

Limited evidence on persistence with anticoagulants, and its effect on the risk of recurrence of venous thromboembolism: a systematic review of observational studies
por: Vora, Pareen, et al.
Publicado: (2016)

Acute Kidney Injury in Patients with Non-Valvular Atrial Fibrillation Treated with Rivaroxaban or Warfarin: A Population-Based Study from the United Kingdom
por: González-Pérez, Antonio, et al.
Publicado: (2022)

Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany
por: Smits, Elisabeth, et al.
Publicado: (2022)

Serological response to nifurtimox in adult patients with chronic Chagas disease: An observational comparative study in Argentina
por: Vizcaya, David, et al.
Publicado: (2021)

Risk Profiles of New Users of Oral Anticoagulants Between 2011 and 2019 in Germany
por: Voss, Annemarie, et al.
Publicado: (2023)

Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden
por: Balabanova, Yanina, et al.
Publicado: (2022)

Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden
por: Balabanova, Yanina, et al.
Publicado: (2022)

Validation of venous thromboembolism diagnoses in patients receiving rivaroxaban or warfarin in The Health Improvement Network
por: Ruigómez, Ana, et al.
Publicado: (2020)

Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke
por: García Rodríguez, Luis A., et al.
Publicado: (2022)

Individual Antidepressants and the Risk of Fractures in Older Adults: A New User Active Comparator Study
por: Pisa, Federica Edith, et al.
Publicado: (2020)

Discontinuation of non-Vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation: a population-based cohort study using primary care data from The Health Improvement Network in the UK
por: Ruigómez, Ana, et al.
Publicado: (2019)

Increased Risk of Stroke Due to Non-adherence and Non-persistence with Direct Oral Anticoagulants (DOACs): Real-World Analyses Using a Nested Case–Control Study from The Netherlands, Italy and Germany
por: Holthuis, Emily, et al.
Publicado: (2022)

Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2021)

The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis
por: Burkill, Sarah, et al.
Publicado: (2019)

User preferences for coworking spaces; a comparison between the Netherlands, Germany and the Czech Republic
por: Appel-Meulenbroek, Rianne, et al.
Publicado: (2020)

Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis
por: Gill, Simrat, et al.
Publicado: (2022)

Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden
por: Hakkarainen, Katja Marja, et al.
Publicado: (2020)

Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism
por: Coleman, Craig I., et al.
Publicado: (2023)

Sampling immigrants in the Netherlands and Germany
por: Salentin, Kurt, et al.
Publicado: (2017)

Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
por: Caroti, Kimberly Snow, et al.
Publicado: (2023)

Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
por: Laliberté, François, et al.
Publicado: (2015)

Safety and effectiveness of appropriately and inappropriately dosed rivaroxaban or apixaban versus warfarin in patients with atrial fibrillation: a cohort study with nested case–control analyses from UK primary care
por: González-Pérez, Antonio, et al.
Publicado: (2022)

Estimating the Beginning of Pregnancy in German Claims Data: Development of an Algorithm With a Focus on the Expected Delivery Date
por: Schink, Tania, et al.
Publicado: (2020)

Corrigendum: Estimating the Beginning of Pregnancy in German Claims Data: Development of an Algorithm With a Focus on the Expected Delivery Date
por: Schink, Tania, et al.
Publicado: (2020)

Incidence of hospital-acquired acute kidney injury and trajectories of glomerular filtration rate in older adults
por: Ebert, Natalie, et al.
Publicado: (2023)

Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
por: Laliberté, François, et al.
Publicado: (2015)

Antidepressants and the risk of traumatic brain injury in the elderly: differences between individual agents
por: Pisa, Federica Edith, et al.
Publicado: (2019)

Vaccine Innovation and Adoption: Polio Vaccines in the UK, the Netherlands and West Germany, 1955–1965
por: LINDNER, ULRIKE, et al.
Publicado: (2006)

Ecological Risk Assessment of Pharmaceuticals in the Transboundary Vecht River (Germany and The Netherlands)
por: Duarte, Daniel J., et al.
Publicado: (2021)

Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany
por: Rivero-Ferrer, Elena, et al.
Publicado: (2022)

Incidence of anogenital warts in Germany: a population-based cohort study
por: Kraut, Angela A, et al.
Publicado: (2010)

Prevention and Control of Multidrug-Resistant Bacteria in The Netherlands and Germany—The Impact of Healthcare Structures
por: Köck, Robin, et al.
Publicado: (2020)

Development and validation of an algorithm to estimate the risk of severe complications of COVID-19: a retrospective cohort study in primary care in the Netherlands
por: Herings, Ron M C, et al.
Publicado: (2021)

Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US Program
por: Caroti, Kimberly Snow, et al.
Publicado: (2023)

Dupuytren's contracture: a retrospective database analysis to determine hospitalizations in the Netherlands
por: Overbeek, Jetty A, et al.
Publicado: (2011)

Comparative Analysis of ESBL-Positive Escherichia coli Isolates from Animals and Humans from the UK, The Netherlands and Germany
por: Wu, Guanghui, et al.
Publicado: (2013)

The Present State of Music in Germany, The Netherlands, and United Provinces /
por: Burney, Charles
Publicado: (2008)

Variegated Squirrel Bornavirus 1 in Squirrels, Germany and the Netherlands
por: Schlottau, Kore, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qa0ffihqo105cims5onascfeaf